Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Novo-Nordisk ADR repsg 1 B Ord Shs NVO

Healthcare
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:NVO)

Wegovy® receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesity

PR Newswire March 8, 2024

Novo Nordisk stock hits new high on next-gen weight-loss drug results

Jonathon Brown March 7, 2024

Novo Nordisk stock rallies on Wegovy diabetes drug trial results

Jonathon Brown August 8, 2023

Novo Nordisk takes actions to help protect US patients from unlawful sales of non-FDA approved medicines claiming to contain semaglutide

PR Newswire June 20, 2023

Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024

PR Newswire March 14, 2023

EXL Announces Appointment of Andreas Fibig to Board of Directors

GlobeNewswire January 12, 2023

SHAREHOLDER ALERT: Weiss Law Investigates Forma Therapeutics Holdings, Inc.

PR Newswire September 1, 2022

Camp Huronda welcomes back campers for a long-awaited reopening and unveils the new Insul-Inn

Canada NewsWire June 23, 2022

DICERNA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dicerna Pharmaceuticals, Inc. - DRNA

PR Newswire December 14, 2021
View More News ››

Opinion & Analysis (NYSE:NVO)

Top First Quarter European ETFs

Benzinga.com  March 31, 2015

A Look At 4 ETFs From The 4 'Least Corrupt' Countries

Benzinga.com  December 4, 2014
View More Opinion ››

Bullboard Posts (NYSE:NVO)

Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs

News; $NVO Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares | BenzingaEli Lilly (NYSE:LLY...
whytestocks - January 31, 2024

Novo Nordisk Skyrockets To $506B Valuation Driven By 'Miracl

News; $NVO Novo Nordisk Skyrockets To $506B Valuation Driven By 'Miracle' Drugs Ozempic, Wegovy | BenzingaNovo Nordisk (NYSE:NVO...
whytestocks - January 31, 2024

Please take a look

https://www.change.org/p/fda-and-ema-improving-the-public-health?recruiter=1170861947&recruited_by_id=6f0edee0-47cf-11eb-a646...
scarlet1967 - May 26, 2021

Bonvoyage12.....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020

wits 1.0 not everywhere either

it is in 7 distinct places, with about 5-15 g/t averages for hundreds of square km's. A dry hole for us is a dry hole. Doesn't...
jonggua - October 11, 2017

UV Flu technologies (UVFT) up over 45% in the last

UV Flu Technologies (OTC BB: UVFT) stock is up over 45% in the last week, and is still severely undervalued at these levels! UVFT's...
jbjohnbedford - October 26, 2010
View more Bullboard ››

Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ...
View More »